These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 1573283

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses.
    Tan H, Derrick J, Hong J, Sanda C, Grosse WM, Edenberg HJ, Taylor M, Seiwert S, Blatt LM.
    J Interferon Cytokine Res; 2005 Oct; 25(10):632-49. PubMed ID: 16241862
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro sensitivity of human metapneumovirus to type I interferons.
    Scagnolari C, Trombetti S, Selvaggi C, Carbone T, Monteleone K, Spano L, Di Marco P, Pierangeli A, Maggi F, Riva E, Antonelli G.
    Viral Immunol; 2011 Apr; 24(2):159-64. PubMed ID: 21449726
    [Abstract] [Full Text] [Related]

  • 29. [Comparison of antiviral activity between FeIFN-omega and FeIFN-alpha].
    Wang H, Jia X, Yang L, Sun L, Wang H, Liu W.
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1556-60. PubMed ID: 19160837
    [Abstract] [Full Text] [Related]

  • 30. [Biological activity of human alpha-interferons studied using specific antisera].
    Korsun NS, Nosik DN, Novokhatskiĭ AS, Trushinskaia GN.
    Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The synergistic effect of human recombinant interferon-alpha 2a in combination with interferon-gamma and the induction of interferon-alpha 2a receptor by interferon-gamma.
    Ishii Y, Tsukagoshi S.
    J Pharmacobiodyn; 1989 May; 12(5):299-304. PubMed ID: 2530332
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Binding of human alpha-interferons to natural killer cells.
    Langer JA, Ortaldo JR, Pestka S.
    J Interferon Res; 1986 Apr; 6(2):97-105. PubMed ID: 2941494
    [Abstract] [Full Text] [Related]

  • 39. Regulation of susceptibility to natural killer cells' cytotoxicity and regulation of HLA synthesis: differing efficacies of alpha, beta, and gamma interferons.
    Wallach D.
    J Interferon Res; 1982 Apr; 2(3):329-38. PubMed ID: 6182251
    [Abstract] [Full Text] [Related]

  • 40. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation.
    François C, Bernard I, Castelain S, Charleston B, Fray MD, Capiod JC, Duverlie G.
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3770-5. PubMed ID: 16127052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.